SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-19-000049
Filing Date
2019-05-08
Accepted
2019-05-08 16:33:07
Documents
13
Period of Report
2019-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nlnk-20190508x8k.htm 8-K 25580
2 PRESS RELEASE nlnk-20190508x8kxex991.htm EX-99.1 110513
3 PRESENTATION q12019earningsslides.htm EX-99.2 13722
4 newlogoa22.jpg GRAPHIC 14001
5 q12019earningsslides001.jpg GRAPHIC 117070
6 q12019earningsslides002.jpg GRAPHIC 73948
7 q12019earningsslides003.jpg GRAPHIC 224031
8 q12019earningsslides004.jpg GRAPHIC 98504
9 q12019earningsslides005.jpg GRAPHIC 73188
10 q12019earningsslides006.jpg GRAPHIC 93176
11 q12019earningsslides007.jpg GRAPHIC 68028
12 q12019earningsslides008.jpg GRAPHIC 110409
13 q12019earningsslides009.jpg GRAPHIC 29372
  Complete submission text file 0001126234-19-000049.txt   1393856
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 19807127
SIC: 2834 Pharmaceutical Preparations